Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold

Biomaterials

Volumn 35, Issue 8, 2014, Pages 2420-2427

  Fagerholm, Per ^a   Lagali, Neil S ^a   Ong, Jeb A ^b   Merrett, Kimberley ^a,c   Jackson, W Bruce ^c   Polarek, James W ^d   Suuronen, Erik J ^e   Liu, Yuwen ^f   Brunette, Isabelle ^b   Griffith, May ^a,d  

^a LINKÖPING UNIVERSITY   (Sweden)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d FIBROGEN INC   (United States)

^e UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^f New Technologies and Research and Development   (United States)

Author keywords

Collagen; Cornea; Recombinant protein; Transplantation

Indexed keywords

CELL DEATH; COLLAGEN; COMPUTER ARCHITECTURE; GRAFTING (CHEMICAL); RECOMBINANT PROTEINS; TRANSPLANTATION (SURGICAL); VISION;

CARBODIIMIDES; CORNEA; DENDRITIC CELLS; MICRO ARCHITECTURES; RECOMBINANT HUMAN COLLAGEN; ROBUST MATERIALS; SHAPE RETENTION; STROMAL CELLS;

SCAFFOLDS (BIOLOGY);

COLLAGEN; CYANAMIDE; DEXAMETHASONE; RECOMBINANT PROTEIN; STEROID;

ADULT; AGED; ARTICLE; CELL DEATH; CELL MIGRATION; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA IMPLANT; CORNEA STROMA; DENDRITIC CELL; DONOR; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KERATOCONUS; MALE; MIDDLE AGED; NERVE CELL; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TISSUE REGENERATION; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

COLLAGEN; CORNEA; RECOMBINANT PROTEIN; TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOCOMPATIBLE MATERIALS; COLLAGEN; CORNEA; FEMALE; HUMANS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; PROSTHESES AND IMPLANTS; RECOMBINANT PROTEINS; REGENERATION; TISSUE SCAFFOLDS; VISUAL ACUITY; YOUNG ADULT;

EID: 84891743194     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.11.079     Document Type: Article

References (32)

1. World Health Organization Visual impairment and blindness 2012, Fact sheet no. 282, Available from URL:. http://www.who.int/mediacentre/factsheets/fs282/en/index.html.
2. World Health Organization. Prevention of blindness and visual impairment: priority eye diseases. Available from URL: http://www.who.int/blindness/causes/priority/en/index9.html.
3. Cornea transplantation fact sheet. Available from URL: http://www.organdonation.nhs.uk/newsroom/fact_sheets/cornea_transplantation_fact_sheet.asp.
4. Claesson M., Armitage W.J., Fagerholm P., Stenevi U. Visual outcome in corneal grafts: a preliminary analysis of the Swedish Corneal Transplant Register. Br J Ophthalmol 2002, 86:174-180.
5. Dandona L., Naduvilath T.J., Janarthanan M., Ragu K., Rao G.N. Survival analysis and visual outcome in a large series of corneal transplants in India. Br J Ophthalmol 1997, 81:726-731.
6. Williams K.A., Lowe M.T., Bartlett C.M., Kelly L., Coster D.J. The Australian Corneal Graft Registry 2007 2007, Report, Flinders University Press, Adelaide, Australia, cited in Coster DJ, Jessup CF, Williams KA. Mechanisms of corneal allograft rejection and regional immunosuppression. Eye 2009; 23:1894-7.
7. Wolfe R.A. Long-term renal allograft survival: a cup half-full and half-empty. Am J Transplant 2004, 4:1215-1216.
8. Fagerholm P., Lagali N.S., Merrett K., Jackson W.B., Munger R., Liu Y., et al. Abiosynthetic alternative to human donor tissue for inducing corneal regeneration: 24 month follow-up of a phase I clinical study. Sci Transl Med 2010, 2:46ra61.
9. Tan D.T. From penetrating to lamellar: the evolution of keratoplasty June 2013, Cataract & Refractive Surgery Today Europe, Available from URL:. http://bmctoday.net/crstodayeurope/2013/06/article.asp?f=from-penetrating-to-lamellar-the-evolution-of-keratoplasty.
10. Liu Y., Gan L., Carlsson D.J., Fagerholm P., Lagali N., Watsky M.A., et al. Asimple, crosslinked collagen tissue substitute for corneal implantation. Invest Ophthalmol Vis Sci 2006, 47:1869-1875.
11. Gratzer P.F., Lee J.M. Control of pH alters the type of cross-linking produced by 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) treatment of acellular matrix vascular grafts. JBiomed Mater Res Appl Biomater 2001, 58:172-179.
12. Priest D., Munger R. Anew instrument for monitoring the optical properties of corneas. Invest Ophthalmol Vis Sci 1998, 39:S352.
13. Ahn J.-I., Kuffova L., Merrett K., Mitra D., Forrester J.V., Li F., et al. Cross-linked collagen hydrogels as corneal implants: effects of sterically bulky versus non-bulky carbodiimides as cross-linkers. Acta Biomater 2013, 9:7796-7805.
14. Laliberté J.F., Meunier J., Chagnon M., Kieffer J.C., Brunette I. Construction of a 3-D atlas of corneal shape. Invest Ophthalmol Vis Sci 2007, 48:1072-1078.
15. Mayer W.J., Irschick U.M., Moser P., Wurm M., Huemer H.P., Romani N., et al. Characterization of antigen-presenting cells in fresh and culture human corneas using novel dendritic cell markers. Invest Ophthalmol Vis Sci 2007, 48:4459-4467.
16. Zhivov A., Stave J., Vollmar B., Guthoff R. Invivo confocal microscopic evaluation of Langerhans cell density and distribution in the corneal epithelium of healthy volunteers and contact lens wearers. Cornea 2007, 26:47-54.
17. Mastropasqua L., Nubile M., Lanzini M., Carpineto P., Ciancaglini M., Pannellini T., et al. Epithelial dendritic cell distribution in normal and inflamed human cornea: invivo confocal microscopy study. Am J Ophthalmol 2006, 142:736-744.
18. Maurice D.M. The eye 1962, 296. Academic Press Inc, New York. H. Davson (Ed.).
19. Crabb R.A., Chau E.P., Evans M.C., Barocas V.H., Hubel A. Biomechanical and microstructural characteristics of a collagen film-based corneal stroma equivalent. Tissue Eng 2006, 12:1565-1575.
20. Jue B., Maurice D.M. The mechanical properties of rabbit and human cornea. JBiomech 1986, 19:1025-1039.
21. Zeng Y., Yang J., Huang K., Lee Z., Lee X. Acomparison of biomechanical properties between human and porcine cornea. JBiomech 2001, 34:533-537.
22. Müller L.J., Marfurt C.F., Kruse F., Tervo T.M. Corneal nerves: structure, contents and function. Exp Eye Res 2003, 76:521-542.
23. Saini J.S., Jain A.K., Sukhija J., Saroha V. Indications and outcome of optical partial thickness lamellar keratoplasty. Cornea 2003, 22:111-113.
24. Tan D.T., Dart J.K., Holland E.J., Kinoshita S. Corneal transplantation. Lancet 2012, 379:1749-1761.
25. Koizumi N., Kinoshita S. The surgical treatment for corneal epithelial stem cell deficiency, corneal epithelial defect and peripheral corneal ulcer. Encyclopaedia of the eye 2010, Vol. 4:239-246. Elseiver, Italy.
26. Chong E.-M., Dana M.R. Graft failure IV. Immunologic mechanisms of corneal transplant rejection. Int Ophthalmol 2008, 28:209-222.
27. Hamrah P., Zhang Q., Liu Y., Dana M.R. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci 2002, 43:639-646.
28. Hackett J.M., Lagali N., Merrett K., Edelhauser E., Sun Y., Gan L., et al. Biosynthetic corneal implants for replacement of pathologic corneal tissue: performance in a controlled rabbit alkali burn model. Invest Ophthalmol Vis Sci 2011, 52:651-657.
29. Kuraitis D., Arzhangi Z., Hyatt A., Vulesevica B., Merrett K., Zhang J., et al. Tertiary biomaterial encapsulation controls the release of FGF-2 without impacting bioactivity. Open Tissue Eng Regen Med J 2012, 5:43-49.
30. Kuraitis D., Ebadi D., Zhang P., Rizzuto E., Vulesevic B., Padavan D.T., et al. Injected matrix stimulates myogenesis and regeneration of mouse skeletal muscle after ischaemic injury. Eur Cell Mater 2012, 24:175-196.
31. Kuraitis D., Zhang P., Zhang Y., Padavan D.T., McEwan K., Sofrenovic T., et al. Astromal cell-derived factor-1 releasing matrix enhances the progenitor cell response and blood vessel growth in ischaemic skeletal muscle. Eur Cell Mater 2011, 22:109-123.
32. Deng C., Zhang P., Vulesevic B., Kuraitis D., Li F., Yang A.F., et al. Acollagen-chitosan hydrogel for endothelial differentiation and angiogenesis. Tissue Eng Part A 2010, 16:3099-3109.